Abiopharma

PNC Announces Planned Common Stock Dividend Increase to $2.00 Per Share

Anfield Energy Delivers Strong First-Half 2026 Momentum with Exceptional PEA Economics and Clear Path to Near-Term Production

Pulsenmore Announces Pricing of $7.5 Million Private Placement with a Single Healthcare Focused Institutional Investor

BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform

IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement

IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement

Axonex and YAS Collaborate with a Global Insurance Group to Develop Embedded Insurance for Robots Innovative InsurTech Solution Drives AI and Robotics Adoption Across Hong Kong and Southeast Asia

MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer

MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer

Formation of Treasury Shares in the Issued Share Capital of Phoenix Financial Ltd